Cargando…

Safety and adverse events following COVID‐19 vaccination among people with epilepsy: A cross‐sectional study

OBJECTIVE: Epilepsy is a non‐communicable disease costing a massive burden globally. It is known that there is increased prevalence of morbidity and mortality following COVID‐19 infection among people with epilepsy (PWE). However, there is limited information about the adverse events following COVID...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ong, Marjorie Jia Yi, Khoo, Ching Soong, Lee, Yi Xuan, Poongkuntran, Vaanee, Tang, Chia Khoi, Choong, Yu Joe, Hod, Rozita, Tan, Hui Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874900/ https://www.ncbi.nlm.nih.gov/pubmed/36214033 http://dx.doi.org/10.1002/epi4.12658

Ejemplares similares

Response: Safety and adverse events following COVID‐19 vaccination among people with epilepsy: Correspondence
por: Ong, Marjorie Jia Yi, et al.
Publicado: (2022)

Safety and adverse events following COVID‐19 vaccination and epilepsy: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Relation of Perceived Stigma to Adverse Events of Medications in Patients with Epilepsy
por: Viteva, Ekaterina
Publicado: (2016)

Adverse Events During Perampanel Adjunctive Therapy in Intractable Epilepsy
por: Youn, Song Ee, et al.
Publicado: (2018)

Validity of the Liverpool Adverse Events Profile as a Screening Tool for Detecting Comorbid Depression or Anxiety Disorder in People with Epilepsy
por: Kwon, Oh-Young, et al.
Publicado: (2018)

Fatty Acid Synthase Beta Dehydratase in the Lipid Biosynthesis Pathway Is Required for Conidiogenesis, Pigmentation and Appressorium Formation in Magnaporthe oryzae S6
por: Sangappillai, Vaanee, et al.
Publicado: (2020)

Experience of adverse events with cerebral propofol testing in patients with drug resistant epilepsy
por: Szantroch, Marta, et al.
Publicado: (2019)

Qualitative electroencephalogram and its predictors in the diagnosis of stroke
por: Ag Lamat, Mohd Syahrul Nizam, et al.
Publicado: (2023)

An Interplay Between Post-Traumatic Epilepsy and Associated Cognitive Decline: A Systematic Review
por: Ngadimon, Irma Wati, et al.
Publicado: (2022)

Adverse Events and Safety Profile of the COVID-19 Vaccines in Adolescents: Safety Monitoring for Adverse Events Using Real-World Data
por: Lee, Chae Won, et al.
Publicado: (2022)

Inappropriate prescribing and adverse drug events in older people
por: Hamilton, Hilary J, et al.
Publicado: (2009)

Dengue Cerebellitis: A Case Report and Literature Review
por: Khoo, Ching Soong
Publicado: (2018)

Adverse Events of Cannabidiol Use in Patients With Epilepsy: A Systematic Review and Meta-analysis
por: Fazlollahi, Asra, et al.
Publicado: (2023)

Adverse Event Profiles of Antiseizure Medications and the Impact of Coadministration on Drug Tolerability in Adults with Epilepsy
por: Willems, Laurent M., et al.
Publicado: (2023)

Balancing Safety and Independence for People With Epilepsy Under Threat of SUDEP
por: Noe, Katherine
Publicado: (2020)

COVID-19 vaccination hesitancy and safety among adult people with epilepsy in eastern China
por: Wang, Shan, et al.
Publicado: (2023)

Anxiety among hospitalized COVID-19 patients: a case–control study from a tertiary teaching hospital in Malaysia
por: Tan, Hui Jan, et al.
Publicado: (2023)

Adoptive T-cell therapy: adverse events and safety switches
por: Tey, Siok-Keen
Publicado: (2014)

Safety of Delafloxacin: Focus on Adverse Events of Special Interest
por: Lodise, Thomas, et al.
Publicado: (2018)

Responding to adverse patient safety events in Viet Nam
por: Harrison, Reema, et al.
Publicado: (2019)

Effects of Mindfulness Meditation on Doctors’ Mindfulness, Patient Safety Culture, Patient Safety Competency and Adverse Event
por: Liu, Chao, et al.
Publicado: (2022)

Hospital costs associated with adverse events in people with diabetes in the UK
por: Keng, Mi Jun, et al.
Publicado: (2022)

O064. Antiepileptic drugs in migraine and epilepsy disorders: who is at increased risk of adverse events?
por: Romoli, Michele, et al.
Publicado: (2015)

Association Between Adverse Events and Discontinuation of Antiepileptic Drugs Among Drug-Naïve Adults with Epilepsy
por: Peasah, Samuel K., et al.
Publicado: (2020)

Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsy
por: Jang, Yoonhyuk, et al.
Publicado: (2021)

Target Adverse Event Profiles for Predictive Safety in the Postmarket Setting
por: Schotland, Peter, et al.
Publicado: (2020)

Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis
por: Lancaster, Lisa H., et al.
Publicado: (2017)

The SMART Safety: An empirical dataset for evidence synthesis of adverse events
por: Fan, Shiqi, et al.
Publicado: (2023)

Progressive Pleural Effusion as an Immune-Related Adverse Event in NSCLC: A Case Report
por: Shen, Chia-I, et al.
Publicado: (2021)

Microbiome transplantation and modulation of immune related adverse events
por: Smibert, Olivia C., et al.
Publicado: (2019)

A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
por: Zou, Shu-peng, et al.
Publicado: (2023)

Safety culture and adverse event reporting in Ghanaian healthcare facilities: Implications for patient safety
por: Abuosi, Aaron Asibi, et al.
Publicado: (2022)

Post-marketing safety surveillance of dalfampridine for multiple sclerosis using FDA adverse event reporting system
por: Xiong, Rui, et al.
Publicado: (2023)

Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated events
por: Fanaroff, Alexander C., et al.
Publicado: (2020)

Case Series of Osmotic Demyelination Syndrome Treated With Plasmapheresis: Experience From Two Tertiary Hospitals
por: Lim, Kuan Yee, et al.
Publicado: (2022)

Patient safety in ICUs: adverse events characterization and potential risk factors
por: Zambon, L, et al.
Publicado: (2011)

Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis
por: Scicchitano, Francesca, et al.
Publicado: (2012)

Pharmacovigilance and drug safety in Calabria (Italy): 2012 adverse events analysis
por: Giofrè, Chiara, et al.
Publicado: (2013)

Reporting of adverse events for marketed drugs: Need for strengthening safety database
por: Apte, Aditi Anand
Publicado: (2016)

Safety of BRAF+MEK Inhibitor Combinations: Severe Adverse Event Evaluation
por: Meirson, Tomer, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3o22ipb3vu23ttm3bq1nq1rlic